This article discusses how IUD manufacturers use legal maneuvers to avoid negligence payments. Indicate the challenges faced by women who are seeking justice.
This article discusses depo provera. Highlights the controversy of discriminatory and unsafe research methods, discusses the drug industry, potential health effects on women, racist practices.
Méthodes de contraception à l’intention des femmes séropositives pour le VIH et des femmes à risque pour le VIH
Media Type:
Online
Author:
National Collaborating Centre for Infectious Diseases
A factsheet on contraception and HIV positive women stating that women should be offered a wide range of contraceptive methods in order to make informed choices regarding reproduction. Twenty-five percent of Women Living with HIV/AIDS (WHA) worldwide have an unmet need for contraception.
Reversible, longterm contraception is relied on by millions of women to prevent unwanted pregnancy. Two very common methods of pregnancy prevention are the use of a copper-containing intrauterine device (IUD) or an injection of a progestogen hormone. We reviewed studies that compared these two highly effective methods and found the IUD to be better at preventing pregnancy than depot medroxyprogesterone acetate (DMPA). Relevant to HIV positive women are the results of one small trial that found that women using the IUD for contraception where less likely to experience a worsening of their HIV disease than those using hormonal contraception. A large, high quality study is urgently needed to shed light on these findings.
Initiative to identify and address barriers to client access and to work to improve family planning service delivery standards and quality. Assistance is provided to such areas as provider training, service management and supervision, client education, and increasing the choice of available contraceptive methods. MAQ also works to distill and disseminate lessons learned and to identify future critical issues that could impact quality care.
Provides guidance for how to safely and effectively use contraceptive methods once they have been deemed medically appropriate. Provides selected evidence-based practice recommendations for use by policy makers, program managers, the scientific community, and national family planning or reproductive health programs. Recommendations are organized into 23 questions.
Examines how first-time contraceptive users are a diverse group that includes young adults who have recently become sexually active and older couples who initiate use after the births of their children.
Examines how community-based distribution programs take contraceptive methods to people where they live, rather than requiring people to visit clinics or other locations for services.
